Covered recipient · General Payments record
DASHAWN L THOMAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$10,853.08
- Reported across 167 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $3,032.97 | 4 |
| Consulting Fee | $1,330.00 | 1 |
| Food and Beverage | $1,215.98 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ardelyx, Inc. | $4,850.35 | 8 |
| ABBVIE INC. | $517.80 | 22 |
| Lilly USA, LLC | $121.87 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.42 | 3 |
| Celltrion USA Inc. | $18.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.17 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301328 | CMS |
| ABBVIE INC. | $145.88 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301330 | CMS |
| ABBVIE INC. | $11.19 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301332 | CMS |
| ABBVIE INC. | $9.82 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301334 | CMS |
| ABBVIE INC. | $30.28 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301336 | CMS |
| ABBVIE INC. | $13.24 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301338 | CMS |
| ABBVIE INC. | $8.44 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301340 | CMS |
| ABBVIE INC. | $31.03 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301342 | CMS |
| ABBVIE INC. | $1.88 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301344 | CMS |
| ABBVIE INC. | $9.45 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301346 | CMS |
| ABBVIE INC. | $12.50 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301348 | CMS |
| ABBVIE INC. | $9.53 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301350 | CMS |
| ABBVIE INC. | $7.12 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301352 | CMS |
| ABBVIE INC. | $24.88 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301354 | CMS |
| ABBVIE INC. | $8.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301356 | CMS |
| ABBVIE INC. | $8.12 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301358 | CMS |
| ABBVIE INC. | $8.32 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301360 | CMS |
| ABBVIE INC. | $122.67 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301362 | CMS |
| ABBVIE INC. | $6.86 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301364 | CMS |
| ABBVIE INC. | $10.54 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301366 | CMS |
| ABBVIE INC. | $13.61 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301368 | CMS |
| ABBVIE INC. | $15.55 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108301370 | CMS |
| Ardelyx, Inc. | $598.00 | 03/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146747835 | CMS |
| Ardelyx, Inc. | $1,985.25 | 03/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146747837 | CMS |
| Ardelyx, Inc. | $422.37 | 03/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146747839 | CMS |
| Ardelyx, Inc. | $168.60 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747841 | CMS |
| Ardelyx, Inc. | $202.71 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747843 | CMS |
| Ardelyx, Inc. | $116.07 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146747845 | CMS |
| Ardelyx, Inc. | $27.35 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1146747847 | CMS |
| Ardelyx, Inc. | $1,330.00 | 05/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1146747849 | CMS |
| Celltrion USA Inc. | $18.51 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075867363 | CMS |
| Lilly USA, LLC | $121.87 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135564962 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.66 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137833393 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.62 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137833395 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.14 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137833397 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.